Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.09
AMSG's Cash to Debt is ranked higher than
59% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. AMSG: 0.09 )
AMSG' s 10-Year Cash to Debt Range
Min: 0.07   Max: 1.51
Current: 0.09

0.07
1.51
Equity to Asset 0.31
AMSG's Equity to Asset is ranked higher than
63% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. AMSG: 0.31 )
AMSG' s 10-Year Equity to Asset Range
Min: 0.31   Max: 0.8
Current: 0.31

0.31
0.8
Interest Coverage 11.45
AMSG's Interest Coverage is ranked higher than
78% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 5.06 vs. AMSG: 11.45 )
AMSG' s 10-Year Interest Coverage Range
Min: 9.19   Max: 65.45
Current: 11.45

9.19
65.45
F-Score: 5
Z-Score: 1.11
M-Score: -2.04
WACC vs ROIC
10.39%
14.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.26
AMSG's Operating margin (%) is ranked higher than
97% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 9.21 vs. AMSG: 24.26 )
AMSG' s 10-Year Operating margin (%) Range
Min: 25.61   Max: 63.3
Current: 24.26

25.61
63.3
Net-margin (%) 3.30
AMSG's Net-margin (%) is ranked higher than
73% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 4.62 vs. AMSG: 3.30 )
AMSG' s 10-Year Net-margin (%) Range
Min: 0.17   Max: 12
Current: 3.3

0.17
12
ROE (%) 4.72
AMSG's ROE (%) is ranked higher than
68% of the 288 Companies
in the Global Medical Care industry.

( Industry Median: 7.86 vs. AMSG: 4.72 )
AMSG' s 10-Year ROE (%) Range
Min: 1.6   Max: 16.3
Current: 4.72

1.6
16.3
ROA (%) 1.53
AMSG's ROA (%) is ranked higher than
68% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 2.80 vs. AMSG: 1.53 )
AMSG' s 10-Year ROA (%) Range
Min: 0.92   Max: 10.16
Current: 1.53

0.92
10.16
ROC (Joel Greenblatt) (%) 137.42
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 12.57 vs. AMSG: 137.42 )
AMSG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 83.63   Max: 204.41
Current: 137.42

83.63
204.41
Revenue Growth (3Y)(%) 14.40
AMSG's Revenue Growth (3Y)(%) is ranked higher than
88% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. AMSG: 14.40 )
AMSG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 9.9   Max: 19.4
Current: 14.4

9.9
19.4
EBITDA Growth (3Y)(%) 12.80
AMSG's EBITDA Growth (3Y)(%) is ranked higher than
85% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. AMSG: 12.80 )
AMSG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9   Max: 40.6
Current: 12.8

-9
40.6
EPS Growth (3Y)(%) 11.70
AMSG's EPS Growth (3Y)(%) is ranked higher than
75% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 13.10 vs. AMSG: 11.70 )
AMSG' s 10-Year EPS Growth (3Y)(%) Range
Min: 1.3   Max: 135.1
Current: 11.7

1.3
135.1
» AMSG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

AMSG Guru Trades in Q1 2014

Joel Greenblatt 123,375 sh (New)
Jim Simons 237,969 sh (+58.12%)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
» More
Q2 2014

AMSG Guru Trades in Q2 2014

Louis Moore Bacon 110,000 sh (New)
Paul Tudor Jones 131,573 sh (New)
Joel Greenblatt 149,988 sh (+21.57%)
Jim Simons 245,469 sh (+3.15%)
» More
Q3 2014

AMSG Guru Trades in Q3 2014

Joel Greenblatt 586,771 sh (+291.21%)
Louis Moore Bacon Sold Out
Jim Simons 19,469 sh (-92.07%)
Paul Tudor Jones 7,700 sh (-94.15%)
» More
Q4 2014

AMSG Guru Trades in Q4 2014

Steven Cohen 215,800 sh (New)
Jim Simons 160,369 sh (+723.71%)
Paul Tudor Jones 11,500 sh (+49.35%)
Joel Greenblatt Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-12-31 Sold Out 0.29%$48.83 - $55.21 $ 60.118%0
Joel Greenblatt 2014-09-30 Add 291.21%0.22%$46.55 - $54.03 $ 60.120%586771
Joel Greenblatt 2014-06-30 Add 21.57%0.02%$40.38 - $52.36 $ 60.131%149988
Joel Greenblatt 2014-03-31 New Buy0.09%$40.4 - $47.08 $ 60.136%123375
Joel Greenblatt 2013-03-31 Sold Out 0.02%$29.41 - $33.64 $ 60.192%0
Joel Greenblatt 2012-12-31 New Buy0.02%$25.98 - $30.47 $ 60.1114%11738
Joel Greenblatt 2011-12-31 Sold Out 0.06%$21.7 - $26.71 $ 60.1141%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Amsurg Corp

SymbolPriceYieldDescription
AMSGP122.742.20

Ratios

vs
industry
vs
history
P/E(ttm) 40.50
AMSG's P/E(ttm) is ranked higher than
77% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 42.70 vs. AMSG: 40.50 )
AMSG' s 10-Year P/E(ttm) Range
Min: 9.07   Max: 40.5
Current: 40.5

9.07
40.5
Forward P/E 14.31
AMSG's Forward P/E is ranked higher than
93% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 26.67 vs. AMSG: 14.31 )
N/A
PE(NRI) 38.10
AMSG's PE(NRI) is ranked higher than
77% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 42.80 vs. AMSG: 38.10 )
AMSG' s 10-Year PE(NRI) Range
Min: 8.55   Max: 38.14
Current: 38.1

8.55
38.14
P/B 1.90
AMSG's P/B is ranked higher than
86% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.17 vs. AMSG: 1.90 )
AMSG' s 10-Year P/B Range
Min: 0.93   Max: 3.4
Current: 1.9

0.93
3.4
P/S 1.60
AMSG's P/S is ranked higher than
73% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.62 vs. AMSG: 1.60 )
AMSG' s 10-Year P/S Range
Min: 0.7   Max: 2.69
Current: 1.6

0.7
2.69
PFCF 6.60
AMSG's PFCF is ranked higher than
97% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 46.75 vs. AMSG: 6.60 )
AMSG' s 10-Year PFCF Range
Min: 1.92   Max: 56.85
Current: 6.6

1.92
56.85
POCF 5.78
AMSG's POCF is ranked higher than
95% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 16.99 vs. AMSG: 5.78 )
AMSG' s 10-Year POCF Range
Min: 1.75   Max: 16.23
Current: 5.78

1.75
16.23
EV-to-EBIT 15.22
AMSG's EV-to-EBIT is ranked higher than
85% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 22.89 vs. AMSG: 15.22 )
AMSG' s 10-Year EV-to-EBIT Range
Min: 3   Max: 14.9
Current: 15.22

3
14.9
PEG 3.77
AMSG's PEG is ranked higher than
89% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 3.77 )
AMSG' s 10-Year PEG Range
Min: 0.3   Max: 87.64
Current: 3.77

0.3
87.64
Shiller P/E 33.00
AMSG's Shiller P/E is ranked higher than
85% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 195.05 vs. AMSG: 33.00 )
AMSG' s 10-Year Shiller P/E Range
Min: 9.92   Max: 43.55
Current: 33

9.92
43.55
Current Ratio 2.37
AMSG's Current Ratio is ranked higher than
93% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. AMSG: 2.37 )
AMSG' s 10-Year Current Ratio Range
Min: 1.91   Max: 4.94
Current: 2.37

1.91
4.94
Quick Ratio 2.29
AMSG's Quick Ratio is ranked higher than
93% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. AMSG: 2.29 )
AMSG' s 10-Year Quick Ratio Range
Min: 1.8   Max: 4.62
Current: 2.29

1.8
4.62
Days Inventory 41.65
AMSG's Days Inventory is ranked higher than
75% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 65.27 vs. AMSG: 41.65 )
AMSG' s 10-Year Days Inventory Range
Min: 11   Max: 46.57
Current: 41.65

11
46.57
Days Sales Outstanding 52.21
AMSG's Days Sales Outstanding is ranked higher than
64% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 51.55 vs. AMSG: 52.21 )
AMSG' s 10-Year Days Sales Outstanding Range
Min: 35.53   Max: 62.96
Current: 52.21

35.53
62.96

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.60
AMSG's Price/DCF (Projected) is ranked higher than
98% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. AMSG: 0.60 )
AMSG' s 10-Year Price/DCF (Projected) Range
Min: 0.24   Max: 2.99
Current: 0.6

0.24
2.99
Price/Median PS Value 1.20
AMSG's Price/Median PS Value is ranked higher than
81% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. AMSG: 1.20 )
AMSG' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 2.11
Current: 1.2

0.5
2.11
Price/Peter Lynch Fair Value 3.80
AMSG's Price/Peter Lynch Fair Value is ranked higher than
89% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 3.80 )
AMSG' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 4.7
Current: 3.8

0.4
4.7
Earnings Yield (Greenblatt) 6.30
AMSG's Earnings Yield (Greenblatt) is ranked higher than
84% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 4.50 vs. AMSG: 6.30 )
AMSG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.3   Max: 33
Current: 6.3

6.3
33
Forward Rate of Return (Yacktman) 24.28
AMSG's Forward Rate of Return (Yacktman) is ranked higher than
90% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 12.07 vs. AMSG: 24.28 )
AMSG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.2   Max: 61
Current: 24.28

0.2
61

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AJH.Germany,
AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.
» More Articles for AMSG

Headlines

Articles On GuruFocus.com
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
predictable Sep 28 2011 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
View on AMSG Apr 30 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 


More From Other Websites
AmSurg Corp. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 26 2015
AmSurg Corp. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 26 2015
AmSurg Reports Fourth-Quarter and 2014 Results Feb 26 2015
Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog Feb 26 2015
Amsurg Corp Earnings Call scheduled for 9:00 am ET today Feb 26 2015
Amsurg beats Street 4Q forecasts Feb 25 2015
Amsurg beats Street 4Q forecasts Feb 25 2015
AMSURG CORP Files SEC form 8-K, Results of Operations and Financial Condition Feb 25 2015
4:04 pm AmSurg beats by $0.06, beats on revs; guides Q1 EPS below consensus; guides FY15 EPS above... Feb 25 2015
AmSurg Reports Fourth-Quarter and 2014 Results Feb 25 2015
Q4 2014 Amsurg Corp Earnings Release - After Market Close Feb 25 2015
Will Ingram Micro (IM) Miss Earnings Estimates in Q4? - Analyst Blog Feb 24 2015
Is a Surprise Coming for AmSurg (AMSG) This Earnings Season? - Tale of the Tape Feb 24 2015
AmSurg Corp. Announces Completion of Exchange Offer For 5.625% Senior Notes Due 2022 Feb 19 2015
AMSURG CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Feb 09 2015
AMSURG CORP Files SEC form 8-K, Change in Directors or Principal Officers Feb 05 2015
Economy And ObamaCare Lift Walk-In Surgery At AmSurg Feb 02 2015
Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog Jan 29 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter and Year-End 2014... Jan 28 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter and Year-End 2014... Jan 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK